Structural basis of different neutralization capabilities of monoclonal antibodies against H7N9 virus
Journal of Virology · 2025
DOI: 10.1128/jvi.01400-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Bingbing Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Animal Disease Control and Prevention & National Data Center for Animal Infectious Diseases, Harbin Veterinary Research Inst…. Hauptthemen laut MEDLINE: Influenza A Virus, H7N9 Subtype, Antibodies, Neutralizing, Antibodies, Viral, Antibodies, Monoclonal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Key Research and Development Program of China (NKPs), MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Neutralizing antibodies (nAbs) are important for the treatment of emerging viral diseases and for effective vaccine development. In this study, we generated and evaluated three nAbs (1H9, 2D7, and C4H4) against H7N9 influenza viruses and found that they differ in their ability to inhibit viral attachment, membrane fusion, and egress. We resolved the cryo-electron microscopy (cryo-EM) structures of H7N9 hemagglutinin (HA) alone and in complex with the nAb antigen-binding fragments (Fabs) and identified the HA head-located epitope for each nAb, thereby revealing the molecular basis and key residues that determine the differences in these nAbs in neutralizing H7N9 viruses. Moreover, we found that the humanized nAb CC4H4 provided complete protection in mice against death caused by a lethal H7N9 virus infection, even when nAb was given 3 days after the mice were infected. These findings provide new insights into the neutralizing mechanism and structural basis for the rational design of H7N9 virus vaccines and therapeutics. IMPORTANCE H7N9 viruses have caused severe infections in both birds and humans since their emergence in early 2013 in China. Their persistent presence and variation in avian populations pose a significant threat to both poultry and humans. There are no treatments for human infections. In this study, we thoroughly investigated the neutralization mechanisms, structural basis, and therapeutic effects of three nAbs (1H9, 2D7, and C4H4) against H7N9 viruses. We revealed the molecular determinants underlying the varied performances of the three nAbs in neutralizing H7N9 viruses and protecting H7N9-infected mice. These insights provide a solid foundation for the rational design of vaccines and therapeutics against H7N9 viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Animal Disease Control and Prevention & National Data Center for Animal Infectious Diseases, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, People's Repu…
- College of Veterinary Medicine, South China Agricultural University, Guangzhou, People's Republic of China.
ORCID-Profile: Bingbing Zhao, Hualan Chen, Jingfei Wang
Förderung
- MOST | National Key Research and Development Program of China (NKPs)
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Zhao, B., Sun, Z., Wang, S., Shi, Z., Jiang, Y., Wang, X., Deng, G., Jiao, P., Chen, H., & Wang, J. (2025). Structural basis of different neutralization capabilities of monoclonal antibodies against H7N9 virus. Journal of Virology. https://doi.org/10.1128/jvi.01400-24
Vancouver
Zhao B, Sun Z, Wang S, Shi Z, Jiang Y, Wang X, et al. Structural basis of different neutralization capabilities of monoclonal antibodies against H7N9 virus. Journal of Virology. 2025. doi:10.1128/jvi.01400-24
BibTeX
@article{Zhao2025,
author = {Zhao, Bingbing and Sun, Zhenzhao and Wang, Shida and Shi, Zhibin and Jiang, Yongping and Wang, Xiurong and Deng, Guohua and Jiao, Peirong and Chen, Hualan and Wang, Jingfei},
title = {Structural basis of different neutralization capabilities of monoclonal antibodies against H7N9 virus},
journal = {Journal of Virology},
year = {2025},
doi = {10.1128/jvi.01400-24}
}
EUVIMED